Cape Cod Incorporated

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia	Bacterial Infections and Mycoses, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pneumocystis infectious disease, Pneumocystis jirovecii Infection, Respiration Disorders, Respiratory Aspiration, fungal infectious disease, fungal lung infectious disease, interstitial lung disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder	Recruiting	Phase 1 / Phase 2	2026-10-09		NCT06892951

Clinical trials